Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Method detects finasteride in plasma and semen with high sensitivity and accuracy.

Acanthosis nigricans in teenage girls with PCOS is a sign of obesity, not insulin resistance or glucose intolerance.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

PON1 levels might indicate hair loss severity, but other health factors can affect this.

Markers help differentiate between apocrine and eccrine sweat glands to identify sweat gland tumors.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

The normalized androgen ratio can help manage conditions with excess androgen activity in women.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Osaterone acetate reduces prostate size and enzyme levels in dogs with benign prostatic hyperplasia.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

K15 staining helps distinguish basal cell carcinoma from trichoepithelioma.

FGF18 is present in beagle dog hair follicles, mainly in the inner root sheath.

Alopecia areata patients have higher hormone levels, suggesting hormonal screening could help in treatment.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Changes in certain RNA and protein levels may contribute to alopecia areata and could be treatment targets.

Hair repigmentation can indicate malignancy and should be investigated.

Certain blood markers can help predict and manage chemotherapy side effects in older cancer patients.

Higher nitric oxide synthase levels in the scalp may influence hair loss in androgenetic alopecia.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Gene variation affects prostate issues and hair loss.

Androgen receptor expression is similar in affected and unaffected scalp areas in androgenetic alopecia.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

ERG increases SOX9, promoting prostate cancer growth and invasion.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

High serum DHT levels can help diagnose PCOS.